Epidemiology and long-term Turku outcome of childhood-onset epilepsy and mortality. Personal experiences. Part I


Share / Export Citation / Email / Print / Text size:

Journal of Epileptology

Foundation of Epileptology

Subject: Medicine


eISSN: 2300-0147





Volume / Issue / page

Volume 26 (2018)
Volume 25 (2017)
Volume 24 (2016)
Volume 23 (2015)
Volume 22 (2014)
Volume 21 (2013)
Related articles

VOLUME 23 , ISSUE 2 (December 2015) > List of articles

Epidemiology and long-term Turku outcome of childhood-onset epilepsy and mortality. Personal experiences. Part I

Matti Sillanpää *

Keywords : childhood-onset epilepsy, incidence of childhood epilepsy, mortality in epilepsy, population-based study, prevalence of childhood epilepsy, temporal changes in the incidence

Citation Information : Journal of Epileptology. Volume 23, Issue 2, Pages 149-157, DOI: https://doi.org/10.1515/joepi-2015-0036

License : (CC BY 4.0)

Received Date : 09-November-2015 / Accepted: 22-December-2015 / Published Online: 23-December-2015



Introduction. Epidemiological studies on epilepsy were long based, with few exceptions, on hospital and institution patients with a subsequent bias toward more difficult cases and the reported prevalence and incidence rates were often obviously too low. Few data are available on the temporal changes in the incidence of epilepsy.

Aim. To study the prevalence and incidence in an unselected child population including all the children living either in the society or in the institution, temporal changes in the incidence and mortality through five decades.

Methods. The most important personal data were reviewed and compared with the relevant data of other investigators.

Results and discussion. The prevalence of epilepsy in our study was 3.2/1000, quite obviously true for the contemporary methodology and well comparable with 3.4–4.2/1000 of other relevant studies published about two decades later and using a more advanced methodology. Similarly, the incidence of 35/100 000, ascertained in two Finnish studies, was comparable with the relevant contemporary literature data. Another study of ours shows that, probably associated with the people “coming from the shadows” and an improved diagnostic methodology, the incidence of childhood epilepsy has increased and is now 60–70/100 000. However, the incidence of childhood epilepsy shows an obvious decreasing trend in the first two decades of the 2000s.

Conclusions. The incidence of childhood epilepsy, in all probability true for the contemporary methodology, was lower than it is now, but it now again shows a decreasing trend.

Content not available PDF Share



International League Against Epilepsy. Commission on Epidemiology and Prognosis: Guidelines for epidemiologic studies on epilepsy. Epilepsia, 1993, 34: 592–596.


Beilmann A., Napa A., Hamarik M., Soot A., Talvik I., Talvik T.: Incidence of childhood epilepsy in Estonia. Brain Dev., 1999, 21: 166–174.


Berg A.T., Shinnar S., Testa F.M., Levy S.R., Smith S.N., Beckerman B.: Mortality in childhood-onset epilepsy. Arch. Pediatr. Adolesc. Med., 2004, 158: 1147–1152.


Berg A.T., Shinnar S., Levy S.R., Testa F.M.: Newly diagnosed epilepsy in children: presentation at diagnosis. Epilepsia, 1999, 40: 445–452.


Blom S., Heijbel J., Bergfors P.G.: Incidence of epilepsy in children: a follow-up study three years after the first seizure. Epilepsia, 1978, 19: 343–50.


Brorson L.: Socialstyrelsen redovisar: Epileptikervården. Epilepsi hos barn och undgdom. En klinisk, psykometrisk och social undersökning inom Uppsala län. (In Swedish, with English summary). Socialstyrelsen, Epileptikervarden, Stockholm 1970.


Brorson L.O., Wranne L.: Long-term prognosis in childhood epilepsy: survival and seizure prognosis. Epilepsia, 1987, 28: 324–330.


Callenbach P.M.C., Westendorp R.G.J., Geerts A.T., Arts W.F.M., Peters E.A.J., Van Donselaar C.A., et al.: Mortality risk in children with epilepsy: the Dutch study of epilepsy in childhood. Pediatrics, 2001, 107: 1259–1263.


Camfield C, Camfield P, Smith B, Gordon K, Dolley J.: Biological factors as predictors of social outcome of epilepsy in intellectually normal children: a population-based study. J. Pediatr., 1993, 122: 869–873.


Camfield C.S., Camfield P.R., Veugelers P.J.: Death in children with epilepsy: a population-based study. Lancet, 2002, 359: 1891–1895.


Camfield C.S., Camfield P.R., Gordon K., Wirrell E., Dooley J.M.: Incidence of epilepsy in childhood and adolescence: a population- based study in Nova Scotia from 1977 to 1985. Epilepsia, 1996, 37: 19–23.


Casetta I., Pugliatti M., Faggioli R., Cesnik E., Simioni V., Bencivelli D. et al.: Incidence of childhood and adolescence epilepsy: a community-based prospective study in the province of Ferrara and in Copparo, Italy, 1996–2005. Eur. J. Neurol., 2012, 19: 312–316.


Christensen J., Vestergaard M., Pedersen M.G., Pedersen C.G., Olsen J., Sidenius P.: Incidence and prevalence of epilepsy in Denmark. Epilepsy Res., 2007, 76: 60–65.


Commission on Classification and Terminology: Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia, 1989, 30: 389–399.


Cross J.H.: Pitfalls in the diagnosis and differential diagnosis of epilepsy. Paediatrics Child Health, 2009, 19: 199–202.


Devinsky O.: Sudden, unexpected death in epilepsy. NEJM, 2011, 365: 1801–1811.


Durá-Travé T., Yoldi-Petri M.E., Gallinas-Victoriano F.: Incidence of epilepsies and epileptic syndromes among children in Navarre, Spain: 2002 through 2005. J. Child. Neurol., 2008, 23: 872–882.


Eriksson K.J., Koivikko M.J.: Prevalence, classification, and severity of epilepsy and epileptic syndromes in children. Epilepsia, 1997, 38: 1275–82.


Ficker D.M., So E.L., Shen W.K., Annegers J.F., O’Brien P.C., Cascino G.D., et al.: Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology, 1998, 51: 1270–1274.


Forsgren L., Beghi E., Oun A., Sillanpää M.: The epidemiology of epilepsy in Europe – a systematic review. Eur. J. Neurol., 2005a, 12: 245–253.


Forsgren L. Hauser A.W., Olafsson E., Sander J.W.A.S., Sillanpää M., Tomson T.: Mortality of epilepsy in developed countries: a review. Epilepsia, 2005b, 46 (Suppl. 11): 18–25.


Freitag C.M., May T.W., Pfäfflin M., König S., Rating D.: Incidence of epilepsies and epileptic syndromes in children and adolescents: A population-based prospective study in Germany. Epilepsia, 2001, 42: 979–985.


Gastaut H.: Clinical and electroencephalographical classification of epileptic seizures. Epilepsia, 1970, 11: 102–113.


Geerts A., Arts W.F., Stroink H., Peeters E., Brouwer O., Peters B., et al.: Course and outcome of childhood epilepsy: A 15- year follow-up of the Dutch Study of Epilepsy in Childhood. Epilepsia, 2010, 51: 1189–1197.


Gissler M., Teperi J., Hemminki E., Merilainen J.: Data quality after restructuring a national medical registry. Scand. J. Soc. Med., 1995, 23: 75–80.


Giussani G., Franchi C., Messina P., Nobili A., Beghi E., EPIRES Group.: Prevalence and incidence of epilepsy in a well-defined population of Northern Italy. Epilepsia, 2014,  55: 1526–1533.


Goodridge D.M., Shorvon S.D.: Epileptic seizures in a population of 6000. I: Demography, diagnosis and classification, and role of the hospital services. Br. Med. J. (Clin. Res. Ed.), 1983, 287: 641–644.


Hart Y.M., Sander J.W.A.S., Shorvon S.D.: National general practice study on epileptic seizures: objectives and study methodology of the largest reported prospective cohort study of epilepsy. NGPSE. Neuroepidemiology, 1989, 8: 221–227.


Hauser W.A., Kurland L.T.: The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia, 1975, 16: 1–66.


Hauser W.A., Annegers J.F., Kurland L.T.: Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia, 1993, 34: 453–68.


Heijbel J., Blom S., Bergfors P.G.: Benign epilepsy in children with centro-temporal EEG foci. A study of incidence rate in outpatient care. Epilepsia, 1975, 16: 657–664.


Helmers S.L., Thurman D.J., Durgin T.L., Kalsanka Pai A., Faught E.: Descriptive epidemiology of epilepsy i the U.S. population: A different approach. Epilepsia, 2015, 56: 942–948.


Jeavons P.M.: The practical management of epilepsy. Update, 1975, 1: 11–15.


Joensen P.: Prevalence, incidence, and classification of epilepsy in the Faroes. Acta Neurol. Scand., 1986, 74: 150–155.


Johannessen S.I., Strandjord R.E.: Concentration of carbamazepine (Tegretol) in serum and in cerebrospinal fluid in patients with epilepsy. Epilepsia, 1973, 14: 373–379.


Juul-Jensen P., Ipsen J.: [Prevalence and incidence of epilepsy in Greater Aarhus]. Ugeskr Laeger, 1975, 137: 2380–2388.


Keränen T. Riekkinen P.J., Sillanpää M.: Incidence and prevalence of epilepsy in adults in eastern Finland. Epilepsia, 1989, 30: 413–421.


Keyes K.M., Utz R.L., Robinson W., Li G.: What is a cohort effect? Comparison of three statistical methods for modeling cohort effects in obesity prevalence in the United States, 1971–2006. Soc. Sci. Med., 2010, 70: 1100–1108.


Keys A., K.M., Fidanza F.: Serum cholesterol studies in Finland. Lancet, 1958, 2: 175–178.


Kudriakova T.B., Sarota L.A., Rozova G.I., Gotkov V.A.: Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites. Br. J. Clin. Pharmacol., 1992, 33: 611–615.


Larsson K., Eeg-Olofsson O.: A population based study of epilepsy in children from a Swedish county. Eur. J. Paediatr. Neurol., 2006, 10: 107–113.


Leach J.P., Lauder R., Nicolson A., Smith D.F.: Epilepsy in the UK: Misdiagnosis, mistreatment, and undertreatment? The Wrexham area epilepsy project. Seizure, 2005, 14: 514–520.


Lennox W.G., Lennox M.A.: Epilepsy and Related Disorders. Little, Brown Co, Boston, 1960.


Meinardi H.: Carbamazepine. In: D.M. Woodbury, J.K. Penry, R.P. Schmidt (eds.), Antiepileptic drugs. Raven Press, New York 1972, 487–496.


Merlis J.K.: Epilepsy in different age groups. In: M. Alter, W.A. Hauser (eds.), The Epidemiology of Epilepsy: A workshop. NINDS Monograph No 14, U.S. Government Printing Office, Washington D.C., 1972, 83–86.


Merlis J.K.: Proposal for an international classification of the epilepsies. Epilepsia, 1970, 11: 114–119.


Meyer F.P., Quednow B., Potrafki A., Koeppe I., Klepel H., Walther H.: Pharmacokinetics of carbamazepine during perinatal period. EEG Clin. Neuropsychol., 1985, 60: 39.


Monaco F., Mutani R., Mastgropaolo C., Tondi M.: Tears asthe best practical indicator of the unbound fraction of an anticonvulsant drug. Epilepsia, 1979, 20: 705–710.


Morselli P.M., Bossi L., Gerna M. (eds.): Pharmacokinetic studies with carbamazepine in epileptic patients. University Park Press, Baltimore 1975.


Nashef L., Shorvon S.D.: Mortality in epilepsy. Epilepsia, 1997, 38: 1059–1061.


Norio R.: Finnish Disease Heritage II: population prehistory and genetic roots of Finns. Hum. Genet., 2003, 112: 457–469.


Novy J., Belluzzo M., Caboclo L.O., Yogarahah M., Martinian L., Peacock J.L., et al.: The lifelong course of chronic epilepsy: the Chalfont experience. Brain, 2013, 136: 3187–3199.


Oun A., Haldre S., Magi M.: Incidence of adult epilepsy in Estonia. Acta Neurol. Scand., 2003, 108: 245–251.


Pietilä K., Tenkanen L., Mänttäri M., Manninen V.: How to define coronary heart disease in register-based follow-up studies: experience from the Helsinki Heart Study. Ann. Med., 1997, 29: 253–259.


Pynnönen S., Sillanpää M. Letter: Carbamazepine and mother’s milk. Lancet, 1975, 2: 563.


Pynnönen S., Frey H., Sillanpää M.: The auto-induction of carbamazepine during long-term therapy. Int. J. Clin. Pharmacol. Ther. Toxicol., 1980, 18: 247–52.


Pynnönen S., Sillanpää M., Frey H., Iisalo E.: Carbamazepine and its 10,11-epoxide in children and adults with epilepsy. Eur. J. Clin. Pharmacol., 1977a, 11: 129–33.


Pynnönen S., Kanto J., Sillanpää M., Erkkola R.: Carbamazepine: placental transport, tissue concentrations in foetus and newborn, and level in milk. Acta Pharmacol. Toxicol., 1977b, 41: 244–253.


Pyörälä K., Salonen J.T., Valkonen T.: Trends in coronary heart disease mortality and morbidity and related factors in Finland. Cardiology, 1985, 72: 35–51.


Rantala H. Ingalsuo H.: Occurrence and outcome of epilepsy in children younger than 2 years. J. Pediatr., 1999, 135: 761–764.


Rapola J.M., Virtamo J., Korhonen P., Haapakoski J., Hartman A.M., Edwards B.K. et al.: Validity of diagnoses of major coronary events in national registers of hospital diagnoses and deaths in Finland. Eur. J. Epidemiol., 1997, 13: 133–138.


Scheepers B., Clough P., Pickles C.: The misdiagnosis of epilepsy: findings of a population study. Seizure, 1998, 7: 403–406.


Shorvon S.: The early history (1909–1961) of Epilepsia, the journal of the International League Against Epilepsy, and its echoes today. Epilepsia, 2007, 48: 1–14.


Shorvon S.D., Goodridge D.M.G.: Longitudinal cohort studies of the prognosis of epilepsy: contribution of the National General Practice Study of Epilepsy and other studies. Brain, 2013, 136: 3497–3510.


Sidenvall R., Forsgren L., Heijbel J.: Prevalence and characteristics of epilepsy in children in northern Sweden. Seizure, 1996, 5: 139–46.


Sidenvall R., Forsgren L., Blomquist H.K., Heijbel J.: A community- based prospective incidence study of epileptic seizures in children. Acta Paediatr., 1993, 82: 60–65.


Sillanpää M.: Carbamazepine. Pharmacology and clinical uses. Acta Neurol. Scand. Suppl., 1981, 88:1–202.


Sillanpää M.: Medico-social prognosis of children with epilepsy. Epidemiological study and analysis of 245 patients. Acta Paediatr. Scand., 1973, 237 (Suppl. 68): 1–104.


Sillanpää M., Shinnar S.: SUDEP and other causes of mortality in childhood onset epilepsy. Epilepsy Behav., 2013, 28: 249–255.


Sillanpää M., Schmidt D.: Seizure clustering during drug treatment affects seizure outcome and mortality of childhood-onset epilepsy. Brain, 2008, 131: 938–944.


Sillanpää M., Jalava M., Shinnar S.: Epilepsy syndromes in patients with childhood-onset seizures in Finland. Pediatr. Neurol., 1999, 21: 533–537.


Sillanpää M., Lastunen S., Helenius H., Schmidt D.: Regional differences and secular trends in the incidence of epilepsy in Finland: a nationwide 23–year registry study. Epilepsia, 2011, 52: 1857–1867.


Sillanpää M., Haataja L., Tomson T., Johannessen S.I.: Carbamazepine. In: S. Shorvon, E. Perucca, J. Engel (eds), The treatment of epilepsy. Wiley-Blackwell, Chichester, UK, 2009, 459–474.


Sillanpää M., Jalava M., Kaleva O., Shinnar S.: Long-term prognosis of seizures with onset in childhood. NEJM, 1998, 338: 1715–1722.


Sillanpää M., Kälviäinen R., Klaukka T., Helenius H., Shinnar S.: Temporal changes in the incidence of epilepsy in Finland: Nationwide study. Epilepsy Res., 2006, 71: 206–215.


Sillanpää M., Anttinen A., Rinne J.O., Joutsa J., Sonninen P., Erkinjuntti M. et al.: Childhood-onset epilepsy five decades later. A prospective population-based cohort study. Epilepsia, 2015, 56: 1774–1783.


Sillanpää M., Shinnar S.: Long-term mortality in childhoodonset epilepsy. NEJM, 2010, 363: 2522–2529.


Terhaag B., Richter K., Dietrich H.: Concentration behavior of carbamazepine in bile and plasma of man. Int. J. Clin. Pharmacol., 1978, 16: 607–609.


Waaler P.E., Blom B.H., Skeidsvoll H., Mykletun A.: Prevalence, classification, and severity of epilepsy in children in western Norway. Epilepsia, 2000, 41: 802–810.